Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07c9542186133097bd6bbb7d92393090 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-60 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C40B40-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-531 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-531 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C40B40-10 |
filingDate |
2015-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2019-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7be49b77bcb0a3b840c199c162fd5b4c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dd53aa60102ace1a66d80dc4faf1c55 |
publicationDate |
2019-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10191056-B2 |
titleOfInvention |
Diagnostic evaluation of antibody responses to commonly recognized prostate cancer-associated antigens |
abstract |
The present invention relates to a plurality of antigens that together form a panel of immunoreactive molecules suitable for identifying candidates for prostate cancer examination. Methods for identifying antibodies indicative of a pre-malignant or malignant prostate are disclosed. Further disclosed are kits that can be used to practice the above methods. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11143656-B2 |
priorityDate |
2010-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |